21st Feb 2012 07:00
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Vesting of options granted under the GlaxoSmithKline Share Option Plan
This notification sets out the vesting of Ordinary Share options made in 2009 under the GlaxoSmithKline Share Option Plan.
The three-year vesting period for the GlaxoSmithKline Share Option Plan options granted in 2009, at an option price of £11.77 per Ordinary share, or US $33.42 in the case of American Depositary Shares (ADS), which commenced on 17 February 2009, came to an end on 16 February 2012. The whole of the option became exercisable on 17 February 2012. Details of those options held by the connected persons of Persons Discharging Managerial Responsibility (PDMR), are given in the table below.
Name of PDMR | Name of Connected person | Number of ADSs vested | Number of Ordinary shares vested |
Mr P Thomson | Mrs K Thomson | 1005 | |
Dr M Slaoui* | Mrs K Slaoui | 1100 |
* denotes an Executive Director
The Company and above named persons were advised of these transactions on 20 February 2012.
The closing middle market price of an Ordinary share of GlaxoSmithKline plc on 17 February 2012 was £14.14.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
20 February 2012
Related Shares:
Glaxosmithkline